InspireMD Inc (NSPR) support and resistance · rev $7.0M
InspireMD Inc (NSPR) is a medical devices company listed on NASDAQ.
This page maps InspireMD Inc (NSPR) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported NSPR revenue for 2024-12-31 was $7.0M. Net income was -$32.0M. Revenue was up 13.0% from 2023-12-31 to 2024-12-31. NSPR currently screens at market cap $34.6M.
NSPR currently screens at market cap $34.6M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new NSPR 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the NSPR quote page for the session range and the stock page for the full model.
Not investment advice.